BB-209

N/A

Report date: 2024/06/21 17:07:12

Base Information

Drug NameBB-209

Drug Alias NameBB-209

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionTumor-associated antigen modulators

TargetsTumor-associated antigen

Therapy Area/IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBright Biologics LLC

China Registration ClassN/A

Develop Information

Active CompaniesBright Biologics LLC

Inactive CompaniesN/A

Active IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A